Main Library
Humana Healthcare Research has released new data showing that Medicare Advantage patients with heart failure who are treated by value-based care (VBC) physicians are significantly more likely to receive recommended therapies than those in traditional care models.
According to Humana’s Value-Based Care Issue Brief, patients in VBC arrangements were nearly 28% more likely to receive full quadruple therapy — the gold-standard, evidence-based regimen for heart failure with reduced ejection fraction (HFrEF).
Heart failure affects more than 6.7 million Americans today, a figure expected to climb as high as 11.4 million by 2050. The condition is one of the leading causes of hospitalization among older adults and carries higher rates of emergency department use and overall health care costs.